Detalhe da pesquisa
1.
Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-ß2-glycoprotein I antibody titers.
Res Pract Thromb Haemost
; 7(1): 100011, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891523
2.
Anti-ß2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
J Thromb Haemost
; 21(9): 2509-2518, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290588
3.
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.
Res Pract Thromb Haemost
; 6(6): e12809, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178455
4.
Anti-ß2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action.
J Thromb Haemost
; 19(4): 1018-1028, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421291
5.
Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia.
Blood Adv
; 6(11): 3347-3351, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255501